Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.

2.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.

Kidney Int. 2019 Jun;95(6):1443-1452. doi: 10.1016/j.kint.2019.01.023. Epub 2019 Mar 15.

PMID:
30982675
3.

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study.

Menne J, Delmas Y, Fakhouri F, Kincaid JF, Licht C, Minetti EE, Mix C, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.

Clin Kidney J. 2018 May 16;12(2):196-205. doi: 10.1093/ckj/sfy035. eCollection 2019 Apr.

4.

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.

BMC Nephrol. 2019 Apr 10;20(1):125. doi: 10.1186/s12882-019-1314-1.

5.

Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers.

Meibody F, Jamme M, Tsatsaris V, Provot F, Lambert J, Frémeaux-Bacchi V, Ducloy-Bouthors AS, Jourdain M, Delmas Y, Perez P, Darmian J, Wynckel A, Rebibou JM, Coppo P, Rafat C, Rondeau E, Frimat L, Hertig A.

Nephrol Dial Transplant. 2019 Feb 25. pii: gfz025. doi: 10.1093/ndt/gfz025. [Epub ahead of print]

PMID:
30805631
6.

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.

Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F.

Blood. 2019 Feb 7;133(6):576-587. doi: 10.1182/blood-2018-09-872028. Epub 2018 Dec 21.

PMID:
30578255
7.

ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw-Schulman Syndrome.

Joly BS, Boisseau P, Roose E, Stepanian A, Biebuyck N, Hogan J, Provot F, Delmas Y, Garrec C, Vanhoorelbeke K, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Thromb Haemost. 2018 Nov;118(11):1902-1917. doi: 10.1055/s-0038-1673686. Epub 2018 Oct 12.

PMID:
30312976
8.

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

Jestin M, Benhamou Y, Schelpe AS, Roose E, Provôt F, Galicier L, Hié M, Presne C, Poullin P, Wynckel A, Saheb S, Deligny C, Servais A, Girault S, Delmas Y, Kanouni T, Lautrette A, Chauveau D, Mousson C, Perez P, Halimi JM, Charvet-Rumpler A, Hamidou M, Cathébras P, Vanhoorelbeke K, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Center.

Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.

PMID:
30201758
9.

Improving the Supply and Quality of Deceased-Donor Organs for Transplantation.

Maanaoui M, Hazzan M, Provôt F.

N Engl J Med. 2018 Aug 16;379(7):692. doi: 10.1056/NEJMc1808003. No abstract available.

PMID:
30124265
10.

Calciphylaxis.

Maanaoui M, Provôt F, Lionet A.

N Engl J Med. 2018 Jul 26;379(4):398. doi: 10.1056/NEJMc1807324. No abstract available.

PMID:
30048064
11.

Rheopheresis for Adjuvant Treatment in Resistant Calciphylaxis.

Bouderlique E, Provot F, Lionet A.

Ther Apher Dial. 2018 Aug;22(4):413-414. doi: 10.1111/1744-9987.12666. Epub 2018 Feb 11. No abstract available.

PMID:
29430867
12.

[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report].

Zaworski J, Frimat M, Duval M, Saint-Jacques C, Bouderlique É, Glowacki F, Noël C, Hazzan M, Provôt F.

Nephrol Ther. 2018 Apr;14(2):112-116. doi: 10.1016/j.nephro.2017.10.004. Epub 2017 Dec 30. French.

PMID:
29295766
13.

A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, Buchler M, Anglicheau D, Merville P, Lang P, Frimat L, Colosio C, Alamartine E, Kamar N, Heng AE, Durrbach A, Moal V, Rivalan J, Etienne I, Peraldi MN, Moreau A, Moulin B; French PTLD Registry.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1663-1670. doi: 10.2215/CJN.03790417. Epub 2017 Aug 17.

14.

Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report.

Maanaoui M, Saint-Jacques C, Gnemmi V, Frimat M, Lionet A, Hazzan M, Noël C, Provot F.

Medicine (Baltimore). 2017 Jun;96(25):e7196. doi: 10.1097/MD.0000000000007196.

15.

Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1237-1247. doi: 10.2215/CJN.00280117. Epub 2017 Jun 8.

16.

[New scores in renal transplantation: How can we use them?]

Hazzan M, Frimat M, Glowacki F, Lionet A, Provot F, Noël C.

Nephrol Ther. 2017 Apr;13 Suppl 1:S131-S136. doi: 10.1016/j.nephro.2017.01.005. French.

PMID:
28577735
17.

[Recommendations for the organ donation from patients with brain or medullary primitive tumors on behalf of the Association of the Neuro-oncologists of French Expression (ANOCEF) and the Club of Neuro-oncology of the French Society of Neurosurgery].

Frappaz D, Le Rhun E, Dagain A, Averland B, Bauchet L, Faure A, Guillaume C, Zouaoui S, Provot F, Vachiery F, Taillandier L, Hoang-Xuan K.

Bull Cancer. 2017 Sep;104(9):771-788. doi: 10.1016/j.bulcan.2017.02.007. Epub 2017 May 23. Review. French.

PMID:
28549594
18.

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome.

Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre.

PLoS One. 2017 May 18;12(5):e0177894. doi: 10.1371/journal.pone.0177894. eCollection 2017.

19.

An avoidable cause of thymoglobulin anaphylaxis.

Brabant S, Facon A, Provôt F, Labalette M, Wallaert B, Chenivesse C.

Allergy Asthma Clin Immunol. 2017 Feb 23;13:13. doi: 10.1186/s13223-017-0186-9. eCollection 2017.

20.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.

Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y.

Am J Hematol. 2017 Apr;92(4):381-387. doi: 10.1002/ajh.24665. Epub 2017 Feb 21.

21.

In Reply to 'Risk of Tranexamic Acid for Treatment of Postpartum Hemorrhage'.

Frimat M, Provôt F, Hertig A.

Am J Kidney Dis. 2017 Jan;69(1):160-161. doi: 10.1053/j.ajkd.2016.10.011. No abstract available.

PMID:
28007188
22.

Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after.

Tabibzadeh N, Glowacki F, Frimat M, Elsermans V, Provôt F, Lionet A, Gnemmi V, Hertig A, Noël C, Hazzan M.

Clin Transplant. 2016 Nov;30(11):1480-1487. doi: 10.1111/ctr.12843. Epub 2016 Oct 13.

PMID:
27623348
23.

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.

Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):50-59. doi: 10.2215/CJN.06440616. Epub 2016 Oct 31.

24.

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors.

Martino S, Jamme M, Deligny C, Busson M, Loiseau P, Azoulay E, Galicier L, Pène F, Provôt F, Dossier A, Saheb S, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies.

PLoS One. 2016 Jul 6;11(7):e0156679. doi: 10.1371/journal.pone.0156679. eCollection 2016.

25.

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.

Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Provôt F, Delmas Y, Perez P, Benhamou Y, Stepanian A, Coppo P, Veyradier A; French Reference Center for Thrombotic Microangiopathies.

Lancet Haematol. 2016 May;3(5):e237-45. doi: 10.1016/S2352-3026(16)30018-7. Epub 2016 Apr 16.

PMID:
27132698
26.

Are there any additional mechanisms for haemolysis in HELLP syndrome?

Sabau L, Terriou L, Provot F, Fourrier F, Roumier C, Caron C, Susen S, Ducloy-Bouthors AS.

Thromb Res. 2016 Jun;142:40-3. doi: 10.1016/j.thromres.2016.03.014. Epub 2016 Apr 9.

PMID:
27128171
27.

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.

Fakhouri F, Hourmant M, Campistol JM, Cataland SR, Espinosa M, Gaber AO, Menne J, Minetti EE, Provôt F, Rondeau E, Ruggenenti P, Weekers LE, Ogawa M, Bedrosian CL, Legendre CM.

Am J Kidney Dis. 2016 Jul;68(1):84-93. doi: 10.1053/j.ajkd.2015.12.034. Epub 2016 Mar 21.

28.

Renal Cortical Necrosis in Postpartum Hemorrhage: A Case Series.

Frimat M, Decambron M, Lebas C, Moktefi A, Lemaitre L, Gnemmi V, Sautenet B, Glowacki F, Subtil D, Jourdain M, Rigouzzo A, Brocheriou I, Halimi JM, Rondeau E, Noel C, Provôt F, Hertig A.

Am J Kidney Dis. 2016 Jul;68(1):50-7. doi: 10.1053/j.ajkd.2015.11.022. Epub 2016 Jan 16.

PMID:
26786299
29.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura.

Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Medicine (Baltimore). 2015 Oct;94(42):e1598. doi: 10.1097/MD.0000000000001598.

30.

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.

Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM, Rivière E, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Chauveau D, Veyradier A, Coppo P.

Am J Hematol. 2015 Jun;90(6):E127-9. doi: 10.1002/ajh.23997. No abstract available.

31.

[Impact of end-stage renal disease and kidney transplantation on the reproductive system].

Delesalle AS, Robin G, Provôt F, Dewailly D, Leroy-Billiard M, Peigné M.

Gynecol Obstet Fertil. 2015 Jan;43(1):33-40. doi: 10.1016/j.gyobfe.2014.11.013. Epub 2014 Dec 17. Review. French.

PMID:
25530544
32.

Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.

Benhamou Y, Boelle PY, Baudin B, Ederhy S, Gras J, Galicier L, Azoulay E, Provôt F, Maury E, Pène F, Mira JP, Wynckel A, Presne C, Poullin P, Halimi JM, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Cohen A, Veyradier A, Coppo P; Reference Center for Thrombotic Microangiopathies.

J Thromb Haemost. 2015 Feb;13(2):293-302. doi: 10.1111/jth.12790. Epub 2014 Dec 18.

33.

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura.

Hie M, Gay J, Galicier L, Provôt F, Presne C, Poullin P, Bonmarchand G, Wynckel A, Benhamou Y, Vanhille P, Servais A, Bordessoule D, Coindre JP, Hamidou M, Vernant JP, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Centre.

Blood. 2014 Jul 10;124(2):204-10. doi: 10.1182/blood-2014-01-550244. Epub 2014 May 28.

34.

Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.

Sicard A, Karras A, Goujon JM, Sirac C, Bender S, Labatut D, Callard P, Sarkozy C, Essig M, Vanhille P, Provot F, Nony A, Nochy D, Ronco P, Bridoux F, Touchard G.

Nephrol Dial Transplant. 2014 Oct;29(10):1894-902. doi: 10.1093/ndt/gfu045. Epub 2014 Mar 11.

PMID:
24619059
35.

Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.

Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.

Am J Kidney Dis. 2014 Jan;63(1):40-8. doi: 10.1053/j.ajkd.2013.07.011. Epub 2013 Sep 8.

PMID:
24021908
36.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.

Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center.

Transfusion. 2014 Feb;54(2):389-97. doi: 10.1111/trf.12263. Epub 2013 May 27.

PMID:
23711330
37.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B.

J Clin Oncol. 2013 Apr 1;31(10):1302-9. doi: 10.1200/JCO.2012.43.2344. Epub 2013 Feb 19.

PMID:
23423742
38.

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschênes G, Lebranchu Y, Zuber J, Loirat C.

Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10.

39.

Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature.

Seidowsky A, Hoffmann M, Glowacki F, Dhaenens CM, Devaux JP, de Sainte Foy CL, Provot F, Gheerbrant JD, Hummel A, Hazzan M, Dracon M, Dieux-Coeslier A, Copin MC, Noël C, Buob D.

Clin Nephrol. 2013 Dec;80(6):456-63. doi: 10.5414/CN107063. Review.

PMID:
22909780
40.

Cast nephropathy and light-chain deposition disease in Waldenström macroglobulinemia.

Gnemmi V, Leleu X, Provot F, Moulonguet F, Buob D.

Am J Kidney Dis. 2012 Sep;60(3):487-91. doi: 10.1053/j.ajkd.2012.01.030. Epub 2012 Jun 20.

PMID:
22721930
41.

Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.

Benhamou Y, Assié C, Boelle PY, Buffet M, Grillberger R, Malot S, Wynckel A, Presne C, Choukroun G, Poullin P, Provôt F, Gruson D, Hamidou M, Bordessoule D, Pourrat J, Mira JP, Le Guern V, Pouteil-Noble C, Daubin C, Vanhille P, Rondeau E, Palcoux JB, Mousson C, Vigneau C, Bonmarchand G, Guidet B, Galicier L, Azoulay E, Rottensteiner H, Veyradier A, Coppo P; Thrombotic Microangiopathies Reference Center.

Haematologica. 2012 Aug;97(8):1181-6. Epub 2012 May 11.

42.

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.

Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V.

Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.

43.

A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V.

Blood. 2012 May 3;119(18):4182-91. doi: 10.1182/blood-2011-10-383281. Epub 2012 Jan 13.

44.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.

PMID:
21926591
45.

Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.

Deltenre P, Moreno C, Tran A, Ollivier I, Provôt F, Stanke F, Lazrek M, Castel H, Canva V, Louvet A, Colin M, Glowacki F, Dharancy S, Henrion J, Hazzan M, Noel C, Mathurin P.

Aliment Pharmacol Ther. 2011 Aug;34(4):454-61. doi: 10.1111/j.1365-2036.2011.04741.x. Epub 2011 Jun 20.

46.

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.

Glowacki F, Lionet A, Buob D, Labalette M, Allorge D, Provôt F, Hazzan M, Noël C, Broly F, Cauffiez C.

Nephrol Dial Transplant. 2011 Sep;26(9):3046-50. doi: 10.1093/ndt/gfr253. Epub 2011 Jun 15.

PMID:
21677300
47.

Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients.

Glowacki F, Lionet A, Hammelin JP, Labalette M, Provôt F, Hazzan M, Broly F, Noël C, Cauffiez C.

Clin Pharmacokinet. 2011 Jul;50(7):451-9. doi: 10.2165/11587050-000000000-00000.

PMID:
21528942
48.

Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis.

Harding S, Provot F, Beuscart JB, Cook M, Bradwell AR, Stringer S, White D, Cockwell P, Hutchison CA.

Nephrol Dial Transplant. 2011 Apr;26(4):1438. doi: 10.1093/ndt/gfr019. Epub 2011 Mar 15.

PMID:
21406545
49.

Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow Up.

Frimat L, Cassuto-Viguier E, Provôt F, Rostaing L, Charpentier B, Akposso K, Moal MC, Lang P, Glotz D, Caillard S, Ducloux D, Pouteil-Noble C, Girardot-Seguin S, Kessler M.

J Transplant. 2010;2010. pii: 402750. doi: 10.1155/2010/402750. Epub 2010 Jul 28.

50.

A prospective randomized study to evaluate the renal impact of surgical revascularization strategy in diabetic patients.

Modine T, Zannis C, Salleron J, Provot F, Gourlay T, Duhamel A, Koussa M, Fayad G.

Interact Cardiovasc Thorac Surg. 2010 Oct;11(4):406-10. doi: 10.1510/icvts.2009.230839. Epub 2010 Jun 30.

PMID:
20591890

Supplemental Content

Loading ...
Support Center